+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

Bioinformatics Collaboration and Licensing Deals 2019-2026 - Product Thumbnail Image

Bioinformatics Collaboration and Licensing Deals 2019-2026

  • Report
  • May 2026
  • 600 Pages
  • Global
From
From
Ovarian Cancer Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Ovarian Cancer Therapeutics - Global Strategic Business Report

  • Report
  • October 2026
  • 118 Pages
  • Global
From
Wearable Injectors Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Wearable Injectors Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Pen Needles Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Pen Needles Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Immuno-oncology Market - Product Thumbnail Image

Immuno-oncology Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
From
Cancer Vaccines Market Report 2023-2033 - Product Thumbnail Image

Cancer Vaccines Market Report 2023-2033

  • Report
  • August 2023
  • 235 Pages
  • Global
From
GLP-1 Analogues Market - Global Strategic Business Report - Product Thumbnail Image

GLP-1 Analogues Market - Global Strategic Business Report

  • Report
  • October 2026
  • 474 Pages
  • Global
From
From
Loading Indicator